JPM vs QNCX · P/E 14, rev $57.35B vs $79.3M cap
JPMorgan Chase & Co (JPM) versus Quince Therapeutics, Inc. (QNCX) — a side-by-side from cached financials, not a winner call.
JPMorgan Chase & Co (JPM) is a banks - diversified company listed on US. It is led by James Dimon.
Quince Therapeutics, Inc. (QNCX) is a biotechnology company listed on US.
Latest reported JPM revenue for 2026-06-30 was $57.35B. Net income was $21.16B. Revenue was up 15.1% from 2026-03-31 to 2026-06-30. JPM currently screens at market cap $805.69B and trailing P/E 14.2.
QNCX does not have a complete income-statement cache yet.
JPM currently screens at market cap $805.69B and trailing P/E 14.2. QNCX currently screens at market cap $79.3M.
Not investment advice. Open the JPM and QNCX stock pages for the full models.
Not investment advice.